Study of Safety and Antitumor Activity of GEN1056 in Participants With Advanced Solid Tumors

NCT05586321 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor, Adult

Interventions

BIOLOGICAL: GEN1056

Sponsor

Genmab

Collaborators

BioNTech SE